Cargando…
HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9
The use of next-generation sequencing (NGS) technologies has been instrumental in the characterization of the mutational landscape of complex human diseases like cancer. But despite the enormous rise in the identification of disease candidate genetic variants, their functionality is yet to be fully...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020200/ https://www.ncbi.nlm.nih.gov/pubmed/36936678 http://dx.doi.org/10.3389/fcell.2023.1111488 |